Searching for Solutions

Thank you for your interest in registering for the Summit, offered by AAPP virtually, October 10-11, 2024. All purchases after the live event provide home study/enduring credit via session recordings.

Email: info@aapp.org  Phone: 402-476-1677 Mailing: 8055 O Street Suite S113 Lincoln, NE 68510

Target Audience The Summit is a 2-day virtual meeting devoted to advancing the care of individuals living with mental illness. Participants in the Summit will improve their ability to care for patients diagnosed with mental illness(es), with a focus on emerging areas of practice and contemporary issues in psychiatric pharmacy at the specialist level. Topics span treatment settings and are of value to all psychiatric pharmacists regardless of the practice setting.

Research at the Forefront The AAPP Foundation Board of Directors is proud to have research as one of the three core pillars in our mission: “As the philanthropic arm of AAPP, our mission is to advance the psychiatric pharmacy profession by supporting research, scholarship, and practitioner development.” In 2024, we extended our commitment.

This award will recognize individual AAPP members who impact change benefiting patient access to care for individuals living with mental illness and/or the profession of psychiatric pharmacy through advocacy with policymakers and/or decision-makers. Advocacy activities under consideration include those with federal and state government as well as other policymaking entities (e.g., regulatory bodies, state boards of pharmacy, agencies, standards bodies, health system administrators, etc.).

The Early Practitioner Award will recognize the efforts of psychiatric pharmacists in the first 5 years of practice or 5 years after completion of post doctoral training. Recipients will have demonstrated commitment to AAPP and its mission to “advance the reach and practice of psychiatric pharmacy and serve as the voice of the specialty.” The recipient serves as a role model for future leaders within AAPP and Psychiatric Pharmacy.

This award will recognize individual AAPP member efforts and accomplishments in increasing patient access to high quality mental health care in exceptional and distinctive ways. This may include activities that increase access to psychiatric pharmacist-led interprofessional care. Examples include reduction and/or mitigation of social determinants of health for people living with mental illness, increased access to novel treatments and/or clinical interventions through research, etc.

Convince Your Supervisor to Support AAPP 2026 Attendance! The merits of the AAPP Annual Meeting are undeniable. Even so, with most organizations having limited travel and education budgets, it may be necessary to show justification when selling your attendance at AAPP 2026.

Pharmacy residency training is considered the gold standard for pharmacists interested in practicing in direct patient care roles across community and inpatient settings. For those wishing to specialize in psychiatric pharmacy, completing a PGY2 psychiatric pharmacy residency is the most efficient process to train qualified psychiatric pharmacist specialists who are eligible to become board-certified in psychiatric pharmacy (BCPP).